Attention Users of Prescription Raptiva

The Food and Drug Administration announced a voluntary recall of the psoriasis drug Raptiva (generic form: Efalizumab). Genentech, the drug’s manufacturer, recalled Raptiva because of a link between long-term use and a severe brain infection, which often results in death.

According to the FDA, patients who are taking Raptiva should immediately cease use of the drug and consult a doctor about changing their treatment plans. However, the drug is not scheduled to be taken off the market until June of 2009.

Although only three Raptiva-caused deaths have been confirmed, users should be aware of the symptoms due to the brain infection. These symptoms include: (1) weakness, clumsiness; (2) visual impairments; (3) speech problems, slurring word; and (4) changes in personality. If you are exhibiting any of these symptoms you should consult a doctor for confirmation.

In addition, Genetech may be liable for any harm suffered as a result of taking the drug. An attorney will be able to further explore Genentech’s negligence or other legal liability.

Disclaimer: The foregoing is general legal information only and not intended to serve as legal advice or a substitute for legal advice. If you have been injured or damaged from using the psoriasis drug Raptiva go to www.ContingencyCase.com to see if there is a lawyer or attorney in your local area who is willing to take your case on a contingency fee basis. ContingencyCase.com is an online legal directory that allows Attorneys to advertise their availability to take all kinds of cases on a contingency fee basis (for example personal injury, eminent domain, contract cases, partnership disputes, etc.). Please note there are no guarantees that any attorney or lawyer will take your case. Copyright 2009 ContingencyCase.com – All Rights Reserved.